-
Love family pledges transformative $5 million gift to help improve care for patients with sickle cell disease, reduce disease-related complicationsThis transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell disease on a local and international level. -
Gene therapy: What to know about the new FDA-approved treatment for sickle cell diseaseSickle cell disease is the most common and clinically significant inherited blood disorder across the nation, and now there is an FDA-approved gene therapy to help those living with SCD. -
Kanter receives $7.7 million grant from the NIH to advance sickle cell disease researchThe NIH grant will advance efforts to reduce the gap between research and care of sickle cell disease. -
New gene therapy could provide cure for sickle cell disease, according to UAB studyAlthough unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement. -
Making the case to improve outcomes for sickle cell diseaseUAB’s Julie Kanter, M.D., says statewide surveillance programs for sickle cell disease can help facilitate progress to improve outcomes.